Skip to main content
Smart Investors Daily
CB

OTC · CBIH

Cannabis Bioscience International Holdings, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Up+$0.00 (+0.00%)

Updated Nov 5, 2026, 12:22 AM

SID Score

4.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
5.81M
P/E ratio
-0.01
Dividend yield
0.00%
52-week range
— – —
Volume
723.35K
Avg. volume
2.79M

Price performance · CBIH

CBIH price history

1M range · 0 trading sessions · Daily adjusted prices

CBIH does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest CBIH news

The latest Smart Investors Daily articles mentioning CBIH.

CBIH research

Overview

Company profile and research snapshot.

Company profile

CANNABIS BIOSCI INTL HLDG

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 19, 2026

CBIH Announces Expanded Research Strategy at the Intersection of Endocannabinoid Science and Biological Medicine

Houston, Texas--(Newsfile Corp. - October 19, 2026) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced an expansion of its scientific research strategy focused on the intersection of endocannabinoid biology, precision medicine, and the development of intellectual property with potential biomedical applications."We are witnessing a new era in the history of medicine: an era in which human biology

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.